John D. McDermott
Algemeen Directeur bij Vascular Therapies, Inc.
Profiel
John D.
McDermott is currently the Chief Executive Officer & Director at Vascular Therapies, Inc. He is also a Director at the International Society of Endovascular Specialists and Paragonix Technologies, Inc. Previously, he served as the Chief Executive Officer & Director at Endologix LLC from 2017 to 2018.
He was also the President, Chief Executive Officer & Director at Trivascular Technologies, Inc. Additionally, he served as the President-Global Sales at C.
R.
Bard, Inc. (New Jersey) and as the Chief Operating Officer & Vice President at Impra, Inc. from 1990 to 1996.
He was the President at Bard Peripheral Vascular Technologies from 2002 to 2007.
He also served as a Director at Entellus Medical, Inc. and the Vascular Disease Foundation.
Mr. McDermott holds an undergraduate degree from Arizona State University and an MBA from Western International University, Inc.
Actieve functies van John D. McDermott
| Bedrijven | Functie | Begin |
|---|---|---|
| International Society of Endovascular Specialists | Directeur/Bestuurslid | - |
Vascular Therapies, Inc.
 Vascular Therapies, Inc. Medical SpecialtiesHealth Technology Vascular Therapies, Inc. operates as a biopharmaceutical firm that develops and commercialize treatments of patients requiring an AV fistula for dialysis. It provides plan on the hemodialysis vascular access indication. The company was founded by Sriram Iyer in 2001 and is headquartered in Cresskill, NJ. | Algemeen Directeur | 01-01-2019 |
Paragonix Technologies, Inc.
 Paragonix Technologies, Inc. Medical SpecialtiesHealth Technology Paragonix Technologies, Inc. manufactures medical devices. Its product portfolio includes SherpaPak Transport Systems, SherpaPak, SherpaPak Kidney Transport System, SherpaKit, SherpaPerfusion, SherpaTrak, and SheraPak Cardiac Transport System. The company was founded by Lisa M. Anderson in 2010 and is headquartered in Braintree, MA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van John D. McDermott
| Bedrijven | Functie | Einde |
|---|---|---|
| ENDOLOGIX, INC. | Algemeen Directeur | 02-05-2018 |
| Bard Peripheral Vascular Technologies | President | 01-01-2007 |
Impra, Inc.
 Impra, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Impra, Inc. is a company that manufactures prosthetic appliances. The company is based in Tempe, AZ. Impra was acquired by C. R. Bard, Inc. (New Jersey), part of Becton, Dickinson & Co. from December 29, 2017 on September 16, 1996 for $143.20 million. | Operationeel Directeur | 01-01-1996 |
| TRIVASCULAR TECHNOLOGIES INC | Algemeen Directeur | - |
| ENTELLUS MEDICAL INC | Directeur/Bestuurslid | - |
Opleiding van John D. McDermott
| Arizona State University | Undergraduate Degree |
| Western International University, Inc. | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
C. R. Bard, Inc. (New Jersey)
 C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
Vascular Therapies, Inc.
Vascular Therapies, Inc. Medical SpecialtiesHealth Technology Vascular Therapies, Inc. operates as a biopharmaceutical firm that develops and commercialize treatments of patients requiring an AV fistula for dialysis. It provides plan on the hemodialysis vascular access indication. The company was founded by Sriram Iyer in 2001 and is headquartered in Cresskill, NJ. | Health Technology |
Entellus Medical, Inc.
 Entellus Medical, Inc. Medical SpecialtiesHealth Technology Entellus Medical, Inc. is a medical technology company, which engages in the design, development, and commercialization of treatment of chronic and recurrent sinusitis in both adult and pediatric patients. The company was founded by Thomas V. Ressemann and Peter Keith in April 2006 and is headquartered in Saint Paul, MN. | Health Technology |
Impra, Inc.
Impra, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Impra, Inc. is a company that manufactures prosthetic appliances. The company is based in Tempe, AZ. Impra was acquired by C. R. Bard, Inc. (New Jersey), part of Becton, Dickinson & Co. from December 29, 2017 on September 16, 1996 for $143.20 million. | Health Technology |
| Bard Peripheral Vascular Technologies | |
Trivascular Technologies, Inc.
 Trivascular Technologies, Inc. Medical SpecialtiesHealth Technology Trivascular Technologies, Inc. operates as a medical device company developing and commercializing technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company was founded on July 11, 2007 and is headquartered in Santa Rosa, CA. | Health Technology |
| International Society of Endovascular Specialists | |
Paragonix Technologies, Inc.
Paragonix Technologies, Inc. Medical SpecialtiesHealth Technology Paragonix Technologies, Inc. manufactures medical devices. Its product portfolio includes SherpaPak Transport Systems, SherpaPak, SherpaPak Kidney Transport System, SherpaKit, SherpaPerfusion, SherpaTrak, and SheraPak Cardiac Transport System. The company was founded by Lisa M. Anderson in 2010 and is headquartered in Braintree, MA. | Health Technology |
| Vascular Disease Foundation |
